title: Back from the brink: catastrophic antiphospholipid syndrome.
authors.affiliation: Department of Medicine, New York Medical College, Valhalla.
authors.forename: Tanush
authors.initials: T
authors.lastname: Gupta
authors.affiliation: Division of Cardiology, Department of Medicine, New York Medical College, Valhalla. Electronic address: sahil_khera@nymc.edu.
authors.forename: Sahil
authors.initials: S
authors.lastname: Khera
authors.affiliation: Department of Medicine, New York Medical College, Valhalla.
authors.forename: Dhaval
authors.initials: D
authors.lastname: Kolte
authors.affiliation: Division of Cardiology, Department of Medicine, New York Medical College, Valhalla.
authors.forename: Wilbert S
authors.initials: WS
authors.lastname: Aronow
authors.affiliation: Division of Cardiology, Department of Medicine, New York Medical College, Valhalla.
authors.forename: Tarunjit
authors.initials: T
authors.lastname: Singh
authors.affiliation: Division of Cardiology, Department of Medicine, New York Medical College, Valhalla.
authors.forename: Sowmya
authors.initials: S
authors.lastname: Pinnamaneni
authors.affiliation: Department of Pathology, New York Medical College, Valhalla.
authors.forename: John T
authors.initials: JT
authors.lastname: Fallon
authors.affiliation: Department of Medicine, New York Medical College, Valhalla.
authors.forename: William H
authors.initials: WH
authors.lastname: Frishman
authors.affiliation: Division of Cardiology, Department of Medicine, New York Medical College, Valhalla.
authors.forename: Alan
authors.initials: A
authors.lastname: Gass
mesh_terms: D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use; D016736:Antiphospholipid Syndrome / Q000150:complications* / Q000175:diagnosis*; D002316:Cardiotonic Agents / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use; D004280:Dobutamine / Q000627:therapeutic use; D015199:Extracorporeal Membrane Oxygenation; D005260:Female; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D008944:Mitral Valve Insufficiency / Q000175:diagnosis / Q000473:pathology; D010956:Plasmapheresis; D012770:Shock, Cardiogenic / Q000175:diagnosis*; D014859:Warfarin / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D002316:Cardiotonic Agents; D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; D004280:Dobutamine; D014859:Warfarin; D003520:Cyclophosphamide; D006493:Heparin; D008775:Methylprednisolone